Long-term effectiveness of antimalarial drugs in rheumatic diseases.
about
Randomized dose-ranging controlled trial of AQ-13, a candidate antimalarial, and chloroquine in healthy volunteersA randomized controlled trial of chloroquine for the treatment of dengue in Vietnamese adultsChloroquine cardiomyopathy: beyond ocular adverse effects.Specific residues of the cytoplasmic domains of cardiac inward rectifier potassium channels are effective antifibrillatory targets.Chloroquine cardiomyopathy - a review of the literature.Rheumatoid arthritis: an overview of new and emerging therapies.Effects of hydroxychloroquine on immune activation and disease progression among HIV-infected patients not receiving antiretroviral therapy: a randomized controlled trial.Can rheumatoid arthritis be prevented?The role of antimalarial agents in the treatment of SLE and lupus nephritis.Current immunotherapy in rheumatoid arthritis.Therapy and pharmacological properties of hydroxychloroquine and chloroquine in treatment of systemic lupus erythematosus, rheumatoid arthritis and related diseases.New Perspectives in Rheumatology: Avoiding Antimalarial Toxicity.Targeting endosomal acidification by chloroquine analogs as a promising strategy for the treatment of emerging viral diseasesChloroquine gestational use in systemic lupus erythematosus: assessing the risk of child ototoxicity by pure tone audiometry.Factors associated with chloroquine-induced retinopathy in rheumatic diseases.Efficacy and safety of methotrexate in articular and cutaneous manifestations of systemic lupus erythematosus.Phase I randomized dose-ascending placebo-controlled trials of ferroquine--a candidate anti-malarial drug--in adults with asymptomatic Plasmodium falciparum infection.Chloroquine increases low-density lipoprotein removal from plasma in systemic lupus patients.Restrictive Cardiomyopathy Associated With Long-Term Use of Hydroxychloroquine for Systemic Lupus Erythematosus.
P2860
Q28469106-1B3E580E-FD22-4B89-ACE7-272BC367B652Q28475036-8D925D75-5823-4657-99C2-E2457FE2F222Q34198175-F9B1C4F2-E55D-4527-A84C-EBA5F46303E0Q34281602-C9D2AA14-F47D-4609-B3B6-F50D11B20F99Q34342236-547179BA-C2EC-4BAB-84D7-6D6E5C34279AQ36160669-A685BC87-E485-412D-9FDF-0A182616FFFCQ37289596-60B4D3DA-6AA2-4E70-A167-07E90204520CQ37589108-D2647B85-B139-4BB9-A3B2-EDC913AB49D9Q37947108-70C9AAC7-0B11-4464-8586-1DCAA1DB9FA4Q38133655-C794D99D-3A5E-4AF0-B686-CEB69FE0905EQ38561490-94ADB827-62B5-4AFA-BFBE-1A7460F2FA84Q38816742-C762AE22-5212-446D-AB7E-899EBFF3CAD9Q39360987-8373FF39-0A87-4204-AB69-806576FB0B15Q41913969-3CEE2519-F0D0-4BE7-8259-297F028DEC01Q41914430-374B52B5-1D31-417B-BF63-849A0E1F437DQ41930370-EB204490-78D6-4276-9C48-7F726646F1D6Q41933350-83E81703-68A1-4A77-A9D1-A92BAED51A32Q41943173-6E9310A0-9030-4FA4-B5BA-CABC6927BBFBQ50882478-12F00172-792A-4215-B7EA-214B35B0654E
P2860
Long-term effectiveness of antimalarial drugs in rheumatic diseases.
description
1998 nî lūn-bûn
@nan
1998 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Long-term effectiveness of antimalarial drugs in rheumatic diseases.
@ast
Long-term effectiveness of antimalarial drugs in rheumatic diseases.
@en
type
label
Long-term effectiveness of antimalarial drugs in rheumatic diseases.
@ast
Long-term effectiveness of antimalarial drugs in rheumatic diseases.
@en
prefLabel
Long-term effectiveness of antimalarial drugs in rheumatic diseases.
@ast
Long-term effectiveness of antimalarial drugs in rheumatic diseases.
@en
P2093
P2860
P356
P1476
Long-term effectiveness of antimalarial drugs in rheumatic diseases.
@en
P2093
Aviña-Zubieta JA
Galindo-Rodriguez G
Russell AS
Suarez-Almazor ME
P2860
P304
P356
10.1136/ARD.57.10.582
P407
P577
1998-10-01T00:00:00Z